The Life Sciences Industrial Strategy, supported by Government and led by Sir John Bell, has been launched today in Birmingham.
30 Aug 2017 Posted in
News Release
By
Press Office
The ABPI has welcomed the launch of the Strategy (available online), that has been developed in consultation with the Life Sciences Industrial Strategy Board. The ABPI and ABPI member companies were active members of the Board.
Alongside creating a new Health Advanced Research Programme (HARP), the Strategy seeks to address a series of challenges under five key themes:
- Science
- Growth
- NHS
- Data
- Skills
Commenting on the launch, ABPI CEO Mike Thompson said:
"Today’s Life Sciences Industrial Strategy is an impressive document which captures the importance of our sector to a successful post-Brexit Britain. Sir John Bell is to be congratulated in pulling together a complex and diverse sector and showing the benefits to the UK of getting us all to align.
We want the UK to be one of the best places in the world for discovering, developing and adopting new medicines and this Strategy provides the focus for all life science partners to work together to deliver exciting medical innovations for patients.
The NHS is rightly at the heart of the strategy: If it can build on its unique capability to use health data in research and development and address the UK’s long-standing challenge of adopting new treatments, it will create a virtuous circle for all and deliver massive health and economic benefits to the UK.
We look forward to working with Government and other partners to implement these recommendations – including through a sector deal with the bio-pharmaceutical industry and a voluntary agreement on UK medicines policy between industry and the Department of Health (see PPRS). These measures will provide confidence for global companies to invest in the UK during and beyond Brexit."
#ENDS#
